Economic Observation Network Blue Sail Medical has been in a volatile market for the past 5 days, performing weaker than the overall market and the industry average. In the past 5 days, the main funds have shown a net outflow overall, with a net proportion close to the market average. On April 13th, the main funds showed a net outflow overall, with a balanced net proportion at the market average level. The margin trading difference accounts for 5.43%.

The market attention of this stock is average, and the overall public opinion is neutral. Institutional research is more frequent, and the overall research report rating has been improved. The latest quarterly report disclosed a change of+0.07% in the holding ratio of active equity funds in this stock. The company has weak profitability, average growth ability, average operational ability, and weak debt paying ability. The current valuation is in the historical high range and at a relatively low level within the industry. The current price to earnings TTM is negative, below the industry median, and has been at 19.93% of individual stocks in the past 5 years.

The above content is based on publicly available information and does not constitute investment advice.